Stock Analysis

Insider Favorites For Growth In January 2025

Published

As global markets navigate a choppy start to 2025, marked by inflation concerns and political uncertainties, investors are keenly watching for opportunities amid fluctuating indices. With U.S. equities experiencing notable declines and small-cap stocks underperforming, the spotlight turns to growth companies with high insider ownership as potential beacons of stability and promise in these turbulent times.

Top 10 Growth Companies With High Insider Ownership

NameInsider OwnershipEarnings Growth
Seojin SystemLtd (KOSDAQ:A178320)30.9%39.9%
People & Technology (KOSDAQ:A137400)16.4%37.3%
Archean Chemical Industries (NSEI:ACI)22.9%41.2%
SKS Technologies Group (ASX:SKS)29.7%24.8%
Kirloskar Pneumatic (BSE:505283)30.3%26.3%
Medley (TSE:4480)34%27.2%
Brightstar Resources (ASX:BTR)16.2%84.3%
Fine M-TecLTD (KOSDAQ:A441270)17.2%131.1%
Fulin Precision (SZSE:300432)13.6%66.7%
HANA Micron (KOSDAQ:A067310)18.3%110.9%

Click here to see the full list of 1474 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

Pandox (OM:PNDX B)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pandox AB (publ) is a hotel property company that owns, develops, and leases hotel properties worldwide with a market cap of SEK36.39 billion.

Operations: The company's revenue is derived from two primary segments: Leases, generating SEK3.85 billion, and Own operation, contributing SEK3.23 billion.

Insider Ownership: 11.1%

Pandox's growth potential is underscored by its forecasted annual profit growth, which exceeds the market average, and expected revenue growth of 6.7% per year. However, recent earnings reveal challenges with a net loss in Q3 2024 despite increased nine-month sales. The company's financial position shows interest payments are not well covered by earnings, and dividends are unsustainable at current levels. Insider ownership remains stable with no significant trading activity reported recently.

OM:PNDX B Earnings and Revenue Growth as at Jan 2025

Vimian Group (OM:VIMIAN)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Vimian Group AB (publ) operates in the global animal health industry and has a market capitalization of approximately SEK20.74 billion.

Operations: The company's revenue is derived from several segments, including Medtech (€112.75 million), Diagnostics (€20.32 million), Specialty Pharma (€163.45 million), and Veterinary Services (€56.11 million).

Insider Ownership: 11.1%

Vimian Group's growth outlook is highlighted by its expected annual earnings increase of 89.7%, outpacing the Swedish market. Despite trading at a good value, recent financials show a Q3 net loss of EUR 2.13 million, contrasting with last year's profit, and insider selling has been significant over the past quarter. Revenue growth is projected at 14.1% annually, slower than desired for high-growth companies but still above market averages.

OM:VIMIAN Earnings and Revenue Growth as at Jan 2025

Shenzhen SEICHI Technologies (SHSE:688627)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Shenzhen SEICHI Technologies Co., Ltd. focuses on the research, development, production, and sale of new display device testing equipment in China with a market cap of CN¥7.32 billion.

Operations: The company's revenue is primarily derived from the research, development, production, and sale of innovative display device testing equipment in China.

Insider Ownership: 18.6%

Shenzhen SEICHI Technologies is positioned for robust growth with a projected annual revenue increase of 29.1%, surpassing the Chinese market average. Despite this, its return on equity is forecasted to remain modest at 11.5% in three years. Recent earnings reports show sales rising to CNY 566.2 million, yet net income slightly declined to CNY 51.38 million from the previous year, reflecting challenges in profitability despite strong top-line growth projections.

SHSE:688627 Earnings and Revenue Growth as at Jan 2025

Taking Advantage

Ready For A Different Approach?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com